HC
BSX icon

Headland Capital’s Boston Scientific BSX Stock Holding History

Headland Capital’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.49M Buy
105,113
+10,856
+12% +$589K 1.11% 18
2026
Q1 		$5.91M Buy
94,257
+3,747
+4% +$300K 1.67% 18
2025
Q4 		$8.63M Sell
90,510
-130
-0.1% -$12.7K 2.4% 13
2025
Q3 		$8.85M Buy
90,640
+936
+1% +$96.9K 2.48% 13
2025
Q2 		$9.64M Buy
89,704
+1,441
+2% +$146K 2.91% 11
2025
Q1 		$8.9M Sell
88,263
-623
-0.7% -$62.7K 2.96% 11
2024
Q4 		$7.94M Buy
+88,886
New +$7.82M 2.72% 13

Other funds holding BSX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Headland Capital's BSX Position: Q2 2026 in Review

Headland Capital increased its Boston Scientific (BSX) stake by 12% in Q2 2026, buying an estimated $589K and bringing the position to 105,113 shares worth $4.49M. The position accounts for 1.11% of the portfolio, ranked #18.

Headland Capital first reported a position in BSX in Q4 2024 and has held it in 7 quarters since. The position peaked at $9.64M in Q2 2025. 1,474 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Headland Capital held 105,113 shares of Boston Scientific worth $4.49M as of Q2 2026.
  • Headland Capital bought 10,856 Boston Scientific shares in Q2 2026, an estimated $589K.
  • Boston Scientific made up 1.11% of Headland Capital's portfolio in Q2 2026, its #18 holding.
  • Headland Capital first reported a position in Boston Scientific in Q4 2024 and has held it in 7 quarters since.
  • Headland Capital's Boston Scientific position peaked at $9.64M in Q2 2025.
  • 1,474 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Headland Capital's 13F filing for Q2 2026, filed 29 Jul 2026.